-
Health Insurance Group Forms Academic Research Network
The national organization of Blue Cross-Blue Shield health insurance providers is linking up with academic researchers to study outcomes of health care practices, including opioid abuse and cancer screenings.
-
Safety, Effects Shown in Drug Clearing Alzheimer’s Peptides
An experimental drug that clears peptides associated with Alzheimer’s disease from the central nervous system was also shown to be safe for patients in an early clinical trial.
-
Synthetic Virus Created to Treat Cancer in Dogs
Two companies partnering with Auburn University developed a synthetic virus to find and destroy tumor cells in a type of bone cancer in dogs.
-
Gene Therapy Shown Helpful with Inherited Skin Disease
An early clinical trial shows genetically engineered skin grafts help heal some open wounds and appear safe for individuals with a serious inherited skin disorder.
-
Clinic Opens for Engineered T-Cell Cancer Therapies
A clinic to provide cancer treatments that use a patient’s immune system cells engineered to fight cancer is open at the Fred Hutchinson Cancer Research Center in Seattle.
-
Spinach Enhanced to Detect Chemicals, Send Signals
A chemical engineering group showed the feasibility of embedding sensors in common spinach plants that can detect and signal the presence of explosive chemicals in the soil.
-
Institutes, Companies Form Business to Bridge Discovery Gap
Three research institutions with pharmaceutical and venture capital companies are creating a new enterprise to fill the drug development gap between proof-of-concept and initial clinical trials.
-
Foundation Medicine, Sarah Cannon Partner on Cancer Trials
Foundation Medicine, a cancer diagnostics company, and Sarah Cannon Research Institute plan to apply genomic testing of patients’ tumors in clinical trials of personalized treatments.
-
Biotech, Univ of Miami Spin-Off Vaccine Company
Biotechnology company Heat Biologics Inc. is licensing research from University of Miami in Florida to develop vaccines against infectious diseases, starting with the Zika virus, in a new subsidiary.
-
Preventive Drugs Offer No Benefit for Children’s Migraine
A clinical trial testing drugs for depression and seizures, but sometimes prescribed to prevent migraines, shows the drugs to be no better than a placebo in preventing migraines among children.